Header Logo

Connection

ALAN SWANN to Dose-Response Relationship, Drug

Back to Details
This is a "connection" page, showing publications ALAN SWANN has written about Dose-Response Relationship, Drug.
ALAN SWANN
Connection Strength
0.353
Dose-Response Relationship, Drug
  1. Pharmacologic mood destabilization: case vignettes. CNS Spectr. 2009 Nov; 14(11 Suppl 11):9-11; discussion 12-4.
    View in: PubMed
    Score: 0.059
  2. Acute yohimbine increases laboratory-measured impulsivity in normal subjects. Biol Psychiatry. 2005 May 15; 57(10):1209-11.
    View in: PubMed
    Score: 0.043
  3. Chronic tiagabine administration and aggressive responding in individuals with a history of substance abuse and antisocial behavior. J Psychopharmacol. 2012 Jul; 26(7):982-93.
    View in: PubMed
    Score: 0.017
  4. Zolmitriptan and human aggression: interaction with alcohol. Psychopharmacology (Berl). 2010 Jul; 210(4):521-31.
    View in: PubMed
    Score: 0.015
  5. Psychostimulants given in adolescence modulate their effects in adulthood using the open field and the wheel-running assays. Brain Res Bull. 2010 May 31; 82(3-4):208-17.
    View in: PubMed
    Score: 0.015
  6. Adolescent and adult male spontaneous hyperactive rats (SHR) respond differently to acute and chronic methylphenidate (Ritalin). Int J Neurosci. 2009; 119(1):40-58.
    View in: PubMed
    Score: 0.014
  7. Methylphenidate sensitization is prevented by prefrontal cortex lesion. Brain Res Bull. 2008 May 15; 76(1-2):131-40.
    View in: PubMed
    Score: 0.013
  8. Chronic administration of methylphenidate produces neurophysiological and behavioral sensitization. Brain Res. 2007 May 11; 1145:66-80.
    View in: PubMed
    Score: 0.012
  9. Acute and chronic methylphenidate dose-response assessment on three adolescent male rat strains. Brain Res Bull. 2006 Dec 11; 71(1-3):301-10.
    View in: PubMed
    Score: 0.012
  10. Chronic methylphenidate modulates locomotor activity and sensory evoked responses in the VTA and NAc of freely behaving rats. Neuropharmacology. 2006 Sep; 51(3):546-56.
    View in: PubMed
    Score: 0.012
  11. Sensory-evoked potentials recordings from the ventral tegmental area, nucleus accumbens, prefrontal cortex, and caudate nucleus and locomotor activity are modulated in dose-response characteristics by methylphenidate. Brain Res. 2006 Feb 16; 1073-1074:164-74.
    View in: PubMed
    Score: 0.011
  12. Extended-release carbamazepine capsules as monotherapy in bipolar disorder : pooled results from two randomised, double-blind, placebo-controlled trials. CNS Drugs. 2006; 20(3):219-31.
    View in: PubMed
    Score: 0.011
  13. Efficacy of oral physostigmine in primary degenerative dementia. A double-blind study of response to different dose level. Psychopharmacology (Berl). 1985; 87(2):147-51.
    View in: PubMed
    Score: 0.011
  14. Differential locomotor responses in male rats from three strains to acute methylphenidate. Int J Neurosci. 2004 Sep; 114(9):1063-84.
    View in: PubMed
    Score: 0.010
  15. Maintenance efficacy of divalproex in the prevention of bipolar depression. Neuropsychopharmacology. 2003 Jul; 28(7):1374-82.
    View in: PubMed
    Score: 0.009
  16. Blockade of sensitization to methylphenidate by MK-801: partial dissociation from motor effects. Neuropharmacology. 2001; 40(2):298-309.
    View in: PubMed
    Score: 0.008
  17. Diurnal differences in sensitization to methylphenidate. Brain Res. 2000 May 02; 864(1):24-39.
    View in: PubMed
    Score: 0.008
  18. MK-801 blocks the development of sensitization to the locomotor effects of methylphenidate. Brain Res Bull. 2000 Apr; 51(6):485-92.
    View in: PubMed
    Score: 0.008
  19. Diurnal differences in amphetamine sensitization. Eur J Pharmacol. 1999 Jun 11; 374(1):1-9.
    View in: PubMed
    Score: 0.007
  20. Dose-related effects of MK-801 on acute and chronic methylphenidate administration. Brain Res. 1998 Dec 14; 814(1-2):78-85.
    View in: PubMed
    Score: 0.007
  21. Diurnal differences in rat's motor response to amphetamine. Eur J Pharmacol. 1998 Mar 19; 345(2):119-28.
    View in: PubMed
    Score: 0.007
  22. Time-dependent differences in the rat's motor response to amphetamine. Pharmacol Biochem Behav. 1998 Feb; 59(2):459-67.
    View in: PubMed
    Score: 0.007
  23. Methylphenidate: diurnal effects on locomotor and stereotypic behavior in the rat. Brain Res. 1997 Nov 28; 777(1-2):1-12.
    View in: PubMed
    Score: 0.006
  24. Behavioral sensitization to cocaine in the absence of altered brain cocaine levels. Pharmacol Biochem Behav. 1997 Aug; 57(4):665-9.
    View in: PubMed
    Score: 0.006
  25. Sensitization to locomotor effects of methylphenidate in the rat. Life Sci. 1997; 61(8):PL101-7.
    View in: PubMed
    Score: 0.006
  26. Dose response characteristics of methylphenidate on different indices of rats' locomotor activity at the beginning of the dark cycle. Brain Res. 1996 Jul 15; 727(1-2):13-21.
    View in: PubMed
    Score: 0.006
  27. Relation of serum valproate concentration to response in mania. Am J Psychiatry. 1996 Jun; 153(6):765-70.
    View in: PubMed
    Score: 0.006
  28. Effects of amphetamine at the beginning of the light cycle on multiple indices of motor activity in the rat. Eur J Pharmacol. 1996 Apr 04; 300(1-2):1-8.
    View in: PubMed
    Score: 0.006
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.